Navigation Links
Zimmer Holdings to Present at Upcoming Investor Conferences

WARSAW, Ind., March 11 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE ZMH; SWX: ZMH), a leader in the orthopaedics industry, announced today it will be participating in the following upcoming investor conferences:

-- March 18, 2008 -- Cowen's 28th Annual Health Care Conference, Boston,

Massachusetts, 8:00 a.m. Eastern Time

-- March 19, 2008 -- Eleventh Annual Lehman Brothers Global Healthcare

Conference, Miami Beach, Florida, 8:30 a.m. Eastern Time

Live webcasts of the presentations can be accessed via Zimmer's Investor Relations website at The webcasts will be archived for replay following the conference.

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer is a worldwide leader in designing, developing, manufacturing and marketing orthopaedic reconstructive, spinal and trauma devices, dental implants, and related orthopaedic surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2007 sales were approximately $3.9 billion. The Company is supported by the efforts of more than 7,500 employees worldwide.

Visit Zimmer on the worldwide web at

SOURCE Zimmer Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Zimmer to Expand Manufacturing Network
2. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
3. Zimmer Reports Fourth Quarter and 2007 Financial Results
4. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
5. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
6. Zimmer Holdings to Present at JPMorgan Healthcare Conference
7. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
8. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
9. Zimmer Holdings to Present at Upcoming Investor Conferences
10. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
11. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from ... at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center ... care topics including advance care planning, healthcare costs and patient and family engagement. ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... --  Pulmatrix, Inc ., (NASDAQ: PULM ), ... today that it was added to the Russell Microcap ... set of U.S. and global equity indexes on June ... for Pulmatrix," said Chief Executive Officer Robert Clarke ... in developing drugs for crucial unmet medical needs, and ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: